Nigerians turn to unproven asthma treatments as inhaler costs rise

ABUJA, NIGERIA — In Nigeria, soaring inhaler costs pose a significant challenge for asthma patients, especially as the world marked Asthma Day this week. The departure of multinational firms like GSK, coupled with inflation, has driven prices skyward, rendering essential medications unaffordable. As a result, patients are turning to alternative treatments. World Asthma Day 2024 finds Nigeria facing a mounting health crisis with asthma medication costs soaring more than 500% in less than a year.